Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04200014
Other study ID # 2019PI198
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 9, 2019
Est. completion date March 31, 2020

Study information

Verified date December 2019
Source Central Hospital, Nancy, France
Contact Guillaume E DE CIANCIO, MD
Phone 0683050105
Email g.deciancio@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Syncope is a common symptom that may be related to a conductive disorder. If no bradycardia is authenticated, it is often necessary to implant an implantable loop recorder.

In somes cases, implantable loop recorder records cardiac conductive disorders. In this study, we want to try to identify a group of patients for whom we could immediately implant a pacemaker without prior implantation of an implantable loop recorder given the high probability of implantation of a pacemaker after interrogation of the implantable loop recorder. It would be interesting for the reduction of interventions for the patients and for the economic aspect of the healthcare system


Recruitment information / eligibility

Status Recruiting
Enrollment 250
Est. completion date March 31, 2020
Est. primary completion date January 31, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- All patients who have benefited from an Implantable Loop recorder in the Nancy's Teaching Hospital

Exclusion Criteria:

- No Exclusion Criteria

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France De Ciancio Vandœuvre-lès-Nancy

Sponsors (1)

Lead Sponsor Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

References & Publications (3)

Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martín A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG; ESC Scientific Document Group . 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018 Jun 1;39(21):1883-1948. doi: 10.1093/eurheartj/ehy037. — View Citation

Edvardsson N, Wolff C, Tsintzos S, Rieger G, Linker NJ. Costs of unstructured investigation of unexplained syncope: insights from a micro-costing analysis of the observational PICTURE registry. Europace. 2015 Jul;17(7):1141-8. doi: 10.1093/europace/euu412. Epub 2015 Mar 10. — View Citation

Padmanabhan D, Kancharla K, El-Harasis MA, Isath A, Makkar N, Noseworthy PA, Friedman PA, Cha YM, Kapa S. Diagnostic and therapeutic value of implantable loop recorder: A tertiary care center experience. Pacing Clin Electrophysiol. 2019 Jan;42(1):38-45. doi: 10.1111/pace.13533. Epub 2018 Dec 4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary significant bradycardia whitch result with an Indication of pacemaker implantation 2° and 3° AV block, sinus node dysfunction with pause > 8 sec or > 3sec with concomitant symptoms, sick sinus syndrom At the moment of enregistrement of a significative arrhythmia or at the end of the 3 years of follow up
Secondary Patient group without benefit of implantation of the Implantable Loop Recorder non significant bradicardia or arythmias revealed by loop recorder during monitoring At the end of the 3 years of follow-up